Pathogenesis of indirect (secondary) acute lung injury

Expert Review of Respiratory Medicine

Volumn 5, Issue 1, 2011, Pages 115-126

  Perl, Mario ^a   Lomas Neira, Joanne ^b   Venet, Fabienne ^c   Chung, Chun Shiang ^b   Ayala, Alfred ^b  

^a UNIVERSITY OF ULM   (Germany)

^b BROWN UNIVERSITY   (United States)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

apoptosis; ARDS; Fas; silencing; small interfering RNA

Indexed keywords

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; BURN; CELL DAMAGE; CELLULAR IMMUNITY; DENDRITIC CELL; EPITHELIUM CELL; HUMAN; LUNG ASPIRATION; LUNG CONTUSION; LYMPHOCYTE; MACROPHAGE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PNEUMONIA; POLYMORPHONUCLEAR CELL; REVIEW; SEPSIS; SHOCK;

EID: 79952181759     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.10.92     Document Type: Review

References (130)

1. Bernard GR, Artigas A, Brigham KL et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149, 818-824 (1994). (Pubitemid 24082248)
2. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 369, 1553-1564 (2007). (Pubitemid 46670280)
3. Peek GJ, Clemens F, Elbourne D et al. CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Serv. Res. 6, 163 (2006).
4. Rubenfeld GD, Caldwell E, Peabody E et al. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353, 1685-1693 (2005). (Pubitemid 41464707)
5. Herridge MS, Angus DC. Acute lung injury - affecting many lives. N. Engl. J. Med. 353, 1736-1738 (2005). (Pubitemid 41464715)
6. Brun-Buisson C, Minelli C, Bertolini G et al. Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med. 30, 51-61 (2004). (Pubitemid 38147107)
7. Goss CH, Brower RG, Hudson LD et al. Incidence of acute lung injury in the United States. Crit. Care Med. 31, 1607-1611 (2003). (Pubitemid 36714211)
8. Yilmaz M, Iscimen R, Keegan MT et al. Six-month survival of patients with acute lung injury: prospective cohort study. Crit. Care Med. 35, 2303-2307 (2007).
9. Calfee CS, Eisner MD, Ware LB et al. Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit. Care Med. 35, 2243-2250 (2007). (Pubitemid 47476219)
10. Vincent JL, Zambon M. Why do patients who have acute lung injury/acute respiratory distress syndrome die from multiple organ dysfunction syndrome? Implications for management. Clin. Chest Med. 27, 725-731 (2006). (Pubitemid 44666251)
11. Monchi M, Bellenfant F, Cariou A et al. Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am. J. Respir. Crit. Care Med. 158, 1076-1081 (1998). (Pubitemid 28489004)
12. ARDS Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N. Engl. J. Med. 342, 1301-1308 (2000).
13. Amato MB, Barbas CS, Medeiros DM et al. Effect of a protective- ventilation strategy on mortality in the acute respiratory distress syndrome. N. Engl. J. Med. 338, 347-354 (1998). (Pubitemid 28083906)
14. Meade MO, Cook DJ, Guyatt GH et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 299, 637-645 (2008). (Pubitemid 351252725)
15. Diaz JV, Brower R, Calfee CS et al. Therapeutic strategies for severe acute lung injury. Crit. Care Med. 38, 1644-1650 (2010).
16. Matthay MA, Zimmerman GA, Esmon C et al. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am. J. Respir. Crit. Care Med. 167, 1027-1035 (2003). (Pubitemid 36408170)
17. Menezes SL, Bozza PT, Faria Neto HC et al. Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. J. Appl. Physiol. 98, 1777-1783 (2005). (Pubitemid 40570789)
18. Gattinoni L, Pelosi P, Suter PM et al. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes? Am. J. Respir. Crit. Care Med. 158, 3-11 (1998). (Pubitemid 28337150)
19. Suntharalingam G, Regan K, Keogh BF et al. Influence of direct and indirect etiology on acute outcome and 6-month functional recovery in acute respiratory distress syndrome. Crit. Care Med. 29, 562-566 (2001). (Pubitemid 32225298)
20. Rocco PR, Zin WA. Pulmonary and extrapulmonary acute respiratory distress syndrome: are they different? Curr. Opin. Crit. Care 11, 10-17 (2005). (Pubitemid 40223714)
21. Pelosi P, DOnofrio D, Chiumello D et al. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur. Respir. J. Suppl. 42, 48s-56s (2003). (Pubitemid 36975737)
22. Pittet JF, Mackersie RC, Martin TR et al. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am. J. Respir. Crit. Care Med. 155, 1187-1205 (1997). (Pubitemid 27172758)
23. Ware LB, Matthay MA. The acute respiratory distress syndrome. N. Engl. J. Med. 342, 1334-1349 (2000). (Pubitemid 30408719)
24. Pratt PC, Vollmer RT, Shelburne JD et al. Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. I. Light microscopy. Am. J. Pathol. 95, 191-214 (1979). (Pubitemid 9164962)
25. Bachofen M, Weibel ER. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin. Chest Med. 3, 35-56 (1982). (Pubitemid 12062058)
26. Bachofen M, Weibel ER. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am. Rev. Respir. Dis. 116, 589-615 (1977). (Pubitemid 8206000)
27. Yang KY, Arcaroli JJ, Abraham E. Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am. J. Respir. Crit. Care Med. 167, 1567-1574 (2003). (Pubitemid 37363369)
28. Warshawski FJ, Sibbald WJ, Driedger AA et al. Abnormal neutrophil-pulmonary interaction in the adult respiratory distress syndrome. Qualitative and quantitative assessment of pulmonary neutrophil kinetics in humans with in vivo 111indium neutrophil scintigraphy. Am. Rev. Respir. Dis. 133, 797-804 (1986). (Pubitemid 16116506)
29. Rinaldo JE, Borovetz H. Deterioration of oxygenation and abnormal lung microvascular permeability during resolution of leukopenia in patients with diffuse lung injury. Am. Rev. Respir. Dis. 131, 579-583 (1985). (Pubitemid 15086744)
30. Azoulay E, Darmon M, Delclaux C et al. Deterioration of previous acute lung injury during neutropenia recovery. Crit. Care Med. 30, 781-786 (2002). (Pubitemid 34297794)
31. Steinberg KP, Milberg JA, Martin TR et al. Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 150, 113-122 (1994). (Pubitemid 24209946)
32. Doerschuk CM. Mechanisms of leukocyte sequestration in inflamed lungs. Microcirculation 8, 71-88 (2001). (Pubitemid 33600461)
33. Lawrence MB, Springer TA. Neutrophils roll on E-selectin. J. Immunol. 151, 6338-6346 (1993). (Pubitemid 23340380)
34. Williams MA, Solomkin JS. Integrin-mediated signaling in human neutrophil functioning. J. Leukoc. Biol. 65, 725-736 (1999). (Pubitemid 29279519)
35. Newman PJ. The biology of PECAM-1. J. Clin. Invest. 100, S25-S29 (1997). (Pubitemid 28009542)
36. Maekawa K, Futami S, Nishida M et al. Effects of trauma and sepsis on soluble L-selectin and cell surface expression of L-selectin and CD11b. J. Trauma 44, 460-468 (1998). (Pubitemid 28153095)
37. Seekamp A, van Griensven M, Hildebrandt F et al. The effect of trauma on neutrophil L-selectin expression and sL-selectin serum levels. Shock 15, 254-260 (2001). (Pubitemid 33596716)
38. Shijo H, Iwabuchi K, Hosoda S et al. Evaluation of neutrophil functions after experimental abdominal surgical trauma. Inflamm. Res. 47, 67-74 (1998). (Pubitemid 28104962)
39. Doerschuk CM, Tasaka S, Wang Q. CD11/CD18-dependent and -independent neutrophil emigration in the lungs: how do neutrophils know which route to take? Am. J. Respir. Cell Mol. Biol. 23, 133-136 (2000). (Pubitemid 30656419)
40. Skoutelis AT, Kaleridis V, Athanassiou GM et al. Neutrophil deformability in patients with sepsis, septic shock, and adult respiratory distress syndrome. Crit. Care Med. 28, 2355-2359 (2000). (Pubitemid 30604439)
41. Suzuki T, Moraes TJ, Vachon E et al. Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells. Am. J. Respir. Cell Mol. Biol. 33, 231-247 (2005). (Pubitemid 41254290)
42. Donnelly SC, MacGregor I, Zamani A et al. Plasma elastase levels and the development of the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151, 1428-1433 (1995).
43. Gando S, Kameue T, Nanzaki S et al. Increased neutrophil elastase, persistent intravascular coagulation, and decreased fibrinolytic activity in patients with posttraumatic acute respiratory distress syndrome. J. Trauma 42, 1068-1072 (1997). (Pubitemid 27287311)
44. Kodama T, Yukioka H, Kato T et al. Neutrophil elastase as a predicting factor for development of acute lung injury. Intern. Med. 46, 699-704 (2007). (Pubitemid 46902263)
45. Endo S, Sato N, Yaegashi Y et al. Sivelestat sodium hydrate improves septic acute lung injury by reducing alveolar dysfunction. Res. Commun. Mol. Pathol. Pharmacol. 119, 53-65 (2006). (Pubitemid 47579200)
46. Hayakawa M, Katabami K, Wada T et al. Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both acute respiratory distress syndrome and disseminated intravascular coagulation patients. Shock 33, 14-18 (2010).
47. Zeiher BG, Artigas A, Vincent JL et al. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit. Care Med. 32, 1695-1702 (2004). (Pubitemid 39050520)
48. Tkalcevic J, Novelli M, Phylactides M et al. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 12, 201-210 (2000). (Pubitemid 30398634)
49. Carney DE, Lutz CJ, Picone AL et al. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation 100, 400-406 (1999). (Pubitemid 29362411)
50. Ricou B, Nicod L, Lacraz S et al. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154, 346-352 (1996). (Pubitemid 26269102)
51. Christner P, Fein A, Goldberg S et al. Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 131, 690-695 (1985). (Pubitemid 15066851)
52. Ayala A, Chung CS, Lomas JL et al. Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency. Am. J. Pathol. 161, 2283-2294 (2002). (Pubitemid 35434872)
53. Lomas-Neira J, Chung CS, Perl M et al. Role of alveolar macrophage and migrating neutrophils in hemorrhage-induced priming for ALI subsequent to septic challenge. Am. J. Physiol. Lung Cell Mol. Physiol. 290, L51-L58 (2006).
54. Stephens KE, Ishizaka A, Wu ZH et al. Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs. Am. Rev. Respir. Dis. 138, 1300-1307 (1988). (Pubitemid 18264506)
55. Inoue S, Nakao A, Kishimoto W et al. Anti-neutrophil antibody attenuates the severity of acute lung injury in rats with experimental acute pancreatitis. Arch. Surg. 130, 93-98 (1995).
56. Clark SC, Rao JN, Flecknell PA et al. Pentoxifylline is as effective as leukocyte depletion for modulating pulmonary reperfusion injury. J. Thorac. Cardiovasc. Surg. 126, 2052-2057 (2003). (Pubitemid 38020771)
57. Looney MR, Su X, Van Ziffle JA et al. Neutrophils and their Fc g receptors are essential in a mouse model of transfusion-related acute lung injury. J. Clin. Invest. 116, 1615-1623 (2006).
58. Heflin JAC, Brigham KL. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J. Clin. Invest. 68, 1253-1260 (1981). (Pubitemid 12235026)
59. Till GO, Johnson KJ, Kunkel R et al. Intravascular activation of complement and acute lung injury. J. Clin. Invest. 69, 1126-1135 (1982).
60. Abraham E, Carmody A, Shenkar R et al. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 279, L1137-L1145 (2000). (Pubitemid 32009500)
61. Lomas-Neira JL, Chung CS, Grutkoski PS et al. CXCR2 inhibition suppresses hemorrhage-induced priming for acute lung injury in mice. J. Leukoc. Biol. 76, 58-64 (2004). (Pubitemid 38857172)
62. Lomas JL, Chung CS, Grutkoski PS et al. Differential effects of macrophage inflammatory chemokine-2 and keratinocyte-derived chemokine on hemorrhage-induced neutrophil priming for lung inflammation: assessment by adoptive cells transfer in mice. Shock 19, 358-365 (2003).
63. Dunican AL, Leuenroth SJ, Grutkoski P et al. TNFa-induced suppression of PMN apoptosis is mediated through interleukin-8 production. Shock 14, 284-288 (2000).
64. Dunican AL, Leuenroth SJ, Ayala A et al. CXC chemokine suppression of polymorphonuclear leukocytes apoptosis and preservation of function is oxidative stress independent. Shock 13, 244-250 (2000).
65. Jimenez MF, Watson RW, Parodo J et al. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. Arch. Surg. 132, 1263-1269 (1997).
66. Ertel W, Keel M, Buergi U et al. Granulocyte colony-stimulating factor inhibits neutrophil apoptosis at the local site after severe head and thoracic injury. J. Trauma 46, 784-792 (1999).
67. Goodman ER, Stricker P, Velavicius M et al. Role of granulocyte- macrophage colony-stimulating factor and its receptor in the genesis of acute respiratory distress syndrome through an effect on neutrophil apoptosis. Arch. Surg. 134, 1049-1054 (1999). (Pubitemid 29473189)
68. Fialkow L, Fochesatto FL, Bozzetti MC et al. Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome. Crit. Care 10, R155 (2006).
69. Kotecha S, Mildner RJ, Prince LR et al. The role of neutrophil apoptosis in the resolution of acute lung injury in newborn infants. Thorax 58, 961-967 (2003). (Pubitemid 37392807)
70. Matute-Bello G, Liles WC, Radella F et al. Neutrophil apoptosis in the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 156, 1969-1977 (1997). (Pubitemid 28011809)
71. Abraham E. Neutrophils and acute lung injury. Crit. Care Med. 31, S195-S199 (2003). (Pubitemid 36458167)
72. Martin TR. Neutrophils and lung injury: getting it right. J. Clin. Invest. 110, 1603-1605 (2002). (Pubitemid 35424236)
73. Nelson S, Belknap SM, Carlson RW et al. A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group. J. Infect. Dis. 178, 1075-1080 (1998). (Pubitemid 28452201)
74. Lagasse E, Weissman IL. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J. Exp. Med. 179, 1047-1052 (1994). (Pubitemid 24065666)
75. Perl M, Chung CS, Perl U et al. Beneficial versus detrimental effects of neutrophils are determined by the nature of the insult. J. Am. Coll. Surg. 204, 840-852 (2007). (Pubitemid 46671580)
76. Teder P, Vandivier RW, Jiang D et al. Resolution of lung inflammation by CD44. Science 296, 155-158 (2002). (Pubitemid 34280077)
77. Laufe MD, Simon RH, Flint A et al. Adult respiratory distress syndrome in neutropenic patients. Am. J. Med. 80, 1022-1026 (1986).
78. Vansteenkiste JF, Boogaerts MA. Adult respiratory distress syndrome in neutropenic leukemia patients. Blut. 58, 287-290 (1989). (Pubitemid 19162785)
79. Ognibene FP, Martin SE, Parker MM et al. Adult respiratory distress syndrome in patients with severe neutropenia. N. Engl. J. Med. 315, 547-551 (1986). (Pubitemid 16052467)
80. Wunderink R, Leeper K Jr, Schein R et al. Filgrastim in patients with pneumonia and severe sepsis or septic shock. Chest 119, 523-529 (2001). (Pubitemid 32163767)
81. Wiener-Kronish JP, Albertine KH, Matthay MA. Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J. Clin. Invest. 88, 864-875 (1991).
82. Walker DC, Behzad AR, Chu F. Neutrophil migration through preexisting holes in the basal laminae of alveolar capillaries and epithelium during streptococcal pneumonia. Microvasc. Res. 50, 397-416 (1995).
83. Modelska K, Pittet JF, Folkesson HG et al. Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits. Am. J. Respir. Crit. Care Med. 160, 1450-1456 (1999).
84. Sznajder JI. Strategies to increase alveolar epithelial fluid removal in the injured lung. Am. J. Respir. Crit. Care Med. 160, 1441-1442 (1999).
85. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 163, 1376-1383 (2001). (Pubitemid 32506602)
86. Matthay MA, Wiener-Kronish JP. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am. Rev. Respir. Dis. 142, 1250-1257 (1990).
87. Baker CS, Evans TW, Randle BJ et al. Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet 353, 1232-1237 (1999). (Pubitemid 29168462)
88. Bardales RH, Xie SS, Schaefer RF et al. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am. J. Pathol. 149, 845-852 (1996). (Pubitemid 26334168)
89. Guinee D Jr, Brambilla E, Fleming M et al. The potential role of BAX and BCL-2 expression in diffuse alveolar damage. Am. J. Pathol. 151, 999-1007 (1997). (Pubitemid 27424309)
90. Nakamura M, Matute-Bello G, Liles WC et al. Differential response of human lung epithelial cells to Fas-induced apoptosis. Am. J. Pathol. 164, 1949-1958 (2004). (Pubitemid 38669344)
91. Albertine KH, Soulier MF, Wang Z et al. Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am. J. Pathol. 161, 1783-1796 (2002). (Pubitemid 35265536)
92. Lee KS, Choi YH, Kim YS et al. Evaluation of bronchoalveolar lavage fluid from ARDS patients with regard to apoptosis. Respir. Med. 102(3), 464-469 (2008). (Pubitemid 351179973)
93. Matute-Bello G, Liles WC, Steinberg KP et al. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J. Immunol. 163, 2217-2225 (1999). (Pubitemid 29382230)
94. Hashimoto S, Kobayashi A, Kooguchi K et al. Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 161, 237-243 (2000). (Pubitemid 30055931)
95. Kiener PA, Davis PM, Rankin BM et al. Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J. Immunol. 159, 1594-1598 (1997). (Pubitemid 127484141)
96. Serrao KL, Fortenberry JD, Owens ML et al. Neutrophils induce apoptosis of lung epithelial cells via release of soluble Fas ligand. Am. J. Physiol. Lung Cell Mol. Physiol. 280, L298-L305 (2001).
97. Powell WC, Fingleton B, Wilson CL et al. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Curr. Biol. 9, 1441-1447 (1999). (Pubitemid 30023478)
98. Matsuno H, Yudoh K, Watanabe Y et al. Stromelysin-1 (MMP-3) in synovial fluid of patients with rheumatoid arthritis has potential to cleave membrane bound Fas ligand. J. Rheumatol. 28, 22-28 (2001). (Pubitemid 32062020)
99. Perl M, Chung CS, Perl U et al. Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury. Crit. Care Med. 38, 1179-1186 (2010).
100. Perl M, Chung CS, Perl U et al. Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. Am. J. Respir. Crit. Care Med. 176, 591-601 (2007). (Pubitemid 47403277)
101. Perl M, Chung CS, Lomas-Neira J et al. Silencing of Fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis. Am. J. Pathol. 167, 1545-1559 (2005). (Pubitemid 41713309)
102. Wortinger MA, Foley JW, Larocque P et al. Fas ligand-induced murine pulmonary inflammation is reduced by a stable decoy receptor 3 analogue. Immunology 110, 225-233 (2003). (Pubitemid 37249262)
103. Matute-Bello G, Winn RK, Jonas M et al. Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: implications for acute pulmonary inflammation. Am. J. Pathol. 158, 153-161 (2001). (Pubitemid 32096480)
104. Matute-Bello G, Frevert CW, Liles WC et al. Fas/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria. Infect. Immun. 69, 5768-5776 (2001). (Pubitemid 32786516)
105. Burns AR, Smith CW, Walker DC. Unique structural features that influence neutrophil emigration into the lung. Physiol. Rev. 83, 309-336 (2003). (Pubitemid 36378675)
106. Predescu SA, Predescu DN, Malik AB. Molecular determinants of endothelial transcytosis and their role in endothelial permeability. Am. J. Physiol. Lung Cell Mol. Physiol. 293, L823-L842 (2007). (Pubitemid 47572231)
107. Agre P. The aquaporin water channels. Proc. Am. Thorac. Soc. 3, 5-13 (2006).
108. Scarpati EM, Sadler JE. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J. Biol. Chem. 264, 20705-20713 (1989). (Pubitemid 20009269)
109. Sabharwal AK, Bajaj SP, Ameri A et al. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. Am. J. Respir. Crit. Care Med. 151, 758-767 (1995).
110. Maniatis NA, Kotanidou A, Catravas JD et al. Endothelial pathomechanisms in acute lung injury. Vascul. Pharmacol. 49, 119-133 (2008).
111. Moloney ED, Evans TW. Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome. Eur. Respir. J. 21, 720-727 (2003). (Pubitemid 36432531)
112. Seki H, Tasaka S, Fukunaga K et al. Effect of Toll-like receptor 4 inhibitor on LPS-induced lung injury. Inflamm. Res. 59, 837-845 (2010).
113. Fullerton DA, Eisenach JH, Friese RS et al. Impairment of endothelial-dependent pulmonary vasorelaxation after mesenteric ischemia/reperfusion. Surgery 120, 879-884 (1996). (Pubitemid 26378191)
114. Rehm M, Bruegger D, Christ F et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 116, 1896-1906 (2007). (Pubitemid 350287085)
115. Atochina EN, Muzykantov VR, Al-Mehdi AB et al. Normoxic lung ischemia/ reperfusion accelerates shedding of angiotensin converting enzyme from the pulmonary endothelium. Am. J. Respir. Crit. Care Med. 156, 1114-1119 (1997).
116. Nowak K, Weih S, Metzger R et al. Immunotargeting of catalase to lung endothelium via anti-angiotensin-converting enzyme antibodies attenuates ischemia-reperfusion injury of the lung in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 293, L162-L169 (2007). (Pubitemid 47080724)
117. Vermaelen K, Pauwels R. Pulmonary dendritic cells. Am. J. Respir. Crit. Care Med. 172, 530-551 (2005). (Pubitemid 41232964)
118. de Heer HJ, Hammad H, Kool M et al. Dendritic cell subsets and immune regulation in the lung. Semin. Immunol. 17, 295-303 (2005). (Pubitemid 40981934)
119. Holt PG, Stumbles PA. Regulation of immunologic homeostasis in peripheral tissues by dendritic cells: the respiratory tract as a paradigm. J. Allergy Clin. Immunol. 105, 421-429 (2000). (Pubitemid 30169895)
120. van Rijt LS, Jung S, Kleinjan A et al. In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J. Exp. Med. 201, 981-991 (2005). (Pubitemid 40524467)
121. Novak N, Bieber T. 2. Dendritic cells as regulators of immunity and tolerance. J. Allergy Clin. Immunol. 121, S370-S374 (2008). (Pubitemid 351172419)
122. Morris PE, Glass J, Cross R et al. Role of T-lymphocytes in the resolution of endotoxin-induced lung injury. Inflammation 21, 269-278 (1997). (Pubitemid 27367829)
123. Nakajima T, Suarez CJ, Lin KW et al. T cell pathways involving CTLA4 contribute to a model of acute lung injury. J. Immunol. 184, 5835-5841 (2010).
124. Venet F, Chung CS, Huang X et al. Lymphocytes in the development of lung inflammation: a role for regulatory CD4+ T cells in indirect pulmonary lung injury. J. Immunol. 183, 3472-3480 (2009).
125. DAlessio FR, Tsushima K, Aggarwal NR et al. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J. Clin. Invest. 119, 2898-2913 (2009).
126. Aggarwal NR, DAlessio FR, Tsushima K et al. Regulatory T cell-mediated resolution of lung injury: identification of potential target genes via expression profiling. Physiol Genomics DOI: 10.1152/ physiolgenomics.00131.2009 (2009) (Epub ahead of print).
127. Venet F, Huang X, Chung CS et al. Plasmacytoid dendritic cells control lung inflammation and monocyte recruitment in indirect acute lung injury in mice. Am. J. Pathol. 176, 764-773 (2010).
128. Tsushima K, King LS, Aggarwal NR et al. Acute lung injury review. Intern. Med. 48, 621-630 (2009).
129. Pene F, Zuber B, Courtine E et al. Dendritic cells modulate lung response to Pseudomonas aeruginosa in a murine model of sepsis-induced immune dysfunction. J. Immunol. 181, 8513-8520 (2008).
130. Benjamim CF, Lundy SK, Lukacs NW et al. Reversal of long-term sepsis-induced immunosuppression by dendritic cells. Blood 105, 3588-3595 (2005). (Pubitemid 40628205)